Private equity finds the right medicine in healthcare

The healthcare private equity (PE) landscape is experiencing a remarkable surge, defying the headwinds of high borrowing costs. According to Bain & Company's recently released 'Global Healthcare Private Equity Report 2025,' the sector achieved $115 billion in deal value during 2024—the second-highest figure on record, trailing only behind the exceptional $151 billion seen in 2021.

This article was originally published on February 01, 2025.